BioCentury | May 29, 2014
Targets & Mechanisms

S100A9-clot not, bleed not

...new findings from U.S. researchers may hand a new indication to at least two companies- InflammatoRx Inc....
...regulate them-but still carry a risk of GI bleeding. Philippe Tessier, president and CSO of InflammatoRx...
...in patients with autoimmune disease might have the added benefit of preventing thrombosis," he said. InflammatoRx...
BioCentury | May 13, 2013
Financial News

InflammatoRx completes venture financing

InflammatoRx Inc. , Quebec City, Quebec Business: Inflammation Date completed: 5/7/13 Type: Venture financing Raised: Not disclosed Investor: AmorChem Venture Fund WIR Staff Inflammation...
Items per page:
1 - 2 of 2
BioCentury | May 29, 2014
Targets & Mechanisms

S100A9-clot not, bleed not

...new findings from U.S. researchers may hand a new indication to at least two companies- InflammatoRx Inc....
...regulate them-but still carry a risk of GI bleeding. Philippe Tessier, president and CSO of InflammatoRx...
...in patients with autoimmune disease might have the added benefit of preventing thrombosis," he said. InflammatoRx...
BioCentury | May 13, 2013
Financial News

InflammatoRx completes venture financing

InflammatoRx Inc. , Quebec City, Quebec Business: Inflammation Date completed: 5/7/13 Type: Venture financing Raised: Not disclosed Investor: AmorChem Venture Fund WIR Staff Inflammation...
Items per page:
1 - 2 of 2